OmniAb, Inc. (OABIW) Financial Statements
Industry: Commercial Physical & Biological Research (Services)
In fiscal 2025, OmniAb reported revenue of $18.7M, down 29.3% from $26.4M the year before. Net income was -$64.8M (a -347.0% net margin), or -$0.57 per diluted share. Operating margin was -369.5%. Operating activities generated -$36.5M of cash, leaving -$37.0M of free cash flow. At fiscal year end, OmniAb held $300.9M in total assets against $33.9M in total liabilities, including $25.5M of cash and equivalents.
Open the full interactive OmniAb financials → Quarterly statements, key ratios, valuation history and price charts.
OmniAb Key Stats
| Share Price | $4.70 |
|---|---|
| Market Cap | $605.3M |
| Revenue YoY Growth | -29.3% |
| 52-Week Range | $1.36 – $5.04 |
| Shares Outstanding | 128.8 million (basic, 2026 Q2) |
OmniAb Income Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Revenue | $59.1M | $34.2M | $26.4M | $18.7M |
| Operating Income | -$26.6M | -$69.4M | -$74.5M | -$69.0M |
| Pre-Tax Income | -$26.1M | -$64.4M | -$71.4M | -$66.3M |
| Income Tax | -$3.7M | -$13.7M | -$9.4M | -$1.5M |
| Net Income | -$22.3M | -$50.6M | -$62.0M | -$64.8M |
| Diluted EPS | -$0.26 | -$0.51 | -$0.61 | -$0.57 |
OmniAb Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.2M | $8.4M | $14.4M | $13.4M |
| Net Income | -$16.5M | -$14.2M | -$7.7M | -$5.9M |
| Diluted EPS | -$0.14 | -$0.12 | -$0.06 | -$0.05 |
OmniAb Balance Sheet
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash & Equivalents | $33.4M | $16.4M | $27.6M | $25.5M |
| Current Assets | $125.0M | $94.9M | $68.1M | $65.3M |
| Total Assets | $421.2M | $375.2M | $325.6M | $300.9M |
| Current Liabilities | $26.0M | $23.1M | $15.1M | $16.3M |
| Total Liabilities | $79.8M | $60.6M | $37.9M | $33.9M |
| Shareholders' Equity | $341.4M | $314.6M | $287.6M | $267.0M |
OmniAb Cash Flow Statement
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|
| Cash From Operations | -$3.6M | $2.3M | -$39.7M | -$36.5M |
| Cash From Investing | -$73.3M | -$18.4M | $37.9M | $6.5M |
| Cash From Financing | $110.7M | -$892,000 | $13.0M | $27.9M |
| Free Cash Flow | -$20.8M | $703,000 | -$41.5M | -$37.0M |
Figures from OmniAb's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full OmniAb financials page for every line item.
OmniAb Company Profile
| Ticker | OABIW |
|---|---|
| Exchange | Nasdaq |
| Industry | Commercial Physical & Biological Research (Services) |
| Headquarters | Emeryville, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0001846253 |
Frequently Asked Questions
What was OmniAb's revenue in fiscal 2025?
OmniAb (OABIW) reported revenue of $18.7M for fiscal 2025.
What is OmniAb's annual revenue history?
OmniAb's annual revenue by fiscal year: 2022: $59.1M; 2023: $34.2M; 2024: $26.4M; 2025: $18.7M.
What was OmniAb's net income in fiscal 2025?
OmniAb reported net income of -$64.8M for fiscal 2025.
What was OmniAb's earnings per share (EPS) in fiscal 2025?
OmniAb's diluted EPS was -$0.57 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did OmniAb generate in fiscal 2025?
OmniAb generated -$37.0M of free cash flow in fiscal 2025.
What was OmniAb's revenue last quarter?
In its most recent reported quarter (2026 Q2), OmniAb reported revenue of $13.4M.
How many shares of OmniAb are outstanding?
OmniAb reported a weighted average of 128.8 million basic shares outstanding in 2026 Q2.
What is OmniAb's market cap?
Based on its latest closing price, OmniAb (OABIW) has a market capitalization of about $605.3M.
When does OmniAb's fiscal year end?
OmniAb's fiscal year end, as registered with the SEC, is December 31.
Where is OmniAb headquartered?
OmniAb lists its business address in Emeryville, California in its SEC filings.
OmniAb Competitors & Similar Companies
See all 12 Commercial Physical & Biological Research (Services) companies →